Coronavirus Disease 2019 (COVID-19)
JMLAB is committed to helping you navigate the global COVID-19 crisis by providing testing, support, and up-to-date information so that you can make the best decisions for your patients.
JMLAB’s stand-alone molecular COVID-19 assay (SARS-CoV-2 by NAA) and SARS-CoV-2 antibody tests are offered under FDA Emergency Use Authorization (EUA). The combined influenza, SARS-CoV-2, and RSV test is a laboratory-developed test (LDT). Fact sheets for the stand-alone molecular assays and for the antibody tests can be found on our COVID-19 Test Information for Hospitals and Labs page. Stand-alone testing for SARS-CoV-2 by NAA on saliva specimens is available.
Sherrie L. Perkins, MD, PhD
Our partnerships are more important than ever as we face these unprecedented challenges together.
Chief Executive Officer, JM-Laboratories
COVID-19 Expertise and Support
Contact your account executive today to find out how JMLAB can support you until operations normalize.
Clinical Trials Support
Our Pharma Services experts are ready to support your COVID-19-related clinical trials.
From workflow to outreach, we can help you navigate the new normal of your lab business.
Your trusted healthcare partner
As the COVID-19 pandemic continues to change how healthcare operates, JMLAB remains committed to providing quality testing and up-to-date guidance so that you can continue to provide the best patient care.
No matter the challenge, we’ll face it together.
Receive COVID-19 Email Updates
To receive email updates about COVID-19 from JMLAB,
enter your email address: